Clinical Trial Update: FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

View source ↗

Summary

FLOWER is a longitudinal epidemiology study by xCures to follow outcomes across multiple rare diseases, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-thalassemia
• Alzheimer Disease
• Amyloidosis
• Amyotrophic Lateral Sclerosis
• Beta-thalassemia
• Creutzfeldt-jakob Disease
• Cystic Fibrosis
• Duchenne Muscular Dystrophy

Snippet

Sponsor: xCures | Conditions: Alpha-Thalassemia, Beta-Thalassemia | Status: RECRUITING